Literature DB >> 3485640

Strategies for in vivo measurement of receptor binding using positron emission tomography.

J S Perlmutter, K B Larson, M E Raichle, J Markham, M A Mintun, M R Kilbourn, M J Welch.   

Abstract

Dopaminergic ligands labeled with positron-emitting radionuclides have been synthesized for quantitative evaluation of dopaminergic binding in vivo. Two different methods, the explicit method and an operationally simplified ratio method, have been proposed for analysis of these positron emission tomographic (PET) data. The basis for both methods is the same three-compartment model. The two methods differ in the assumptions necessary for practical implementation. We have compared these two approaches using PET data obtained in our laboratory. Sequential scans and serial arterial blood samples from a baboon following intravenous injection of [18F]spiroperidol were collected. Application of the two methods to the same data yielded different values for corresponding parameters. Values calculated by the ratio method for the specific rate constant describing receptor binding varied depending upon the time after tracer injection, thus demonstrating an internal inconsistency in this approach. Tracer metabolism markedly affected the binding measurements calculated with either method and thus cannot be ignored. Our results indicate that the adoption of simplifying assumptions for operational convenience can lead to substantial errors and must be done with caution. Alternatively, we present simple new analytical solutions of the tracer conservation equations describing the complete, unsimplified three-compartment model that vastly reduce the computations necessary to implement the explicit method.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3485640     DOI: 10.1038/jcbfm.1986.29

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  Maps of receptor binding parameters in the human brain--a kinetic analysis of PET measurements.

Authors:  G Blomqvist; S Pauli; L Farde; L Eriksson; A Persson; C Halldin
Journal:  Eur J Nucl Med       Date:  1990

Review 2.  Uses and limitations of positron emission tomography in clinical pharmacokinetics/dynamics (Part II).

Authors:  L L Ponto; J A Ponto
Journal:  Clin Pharmacokinet       Date:  1992-04       Impact factor: 6.447

3.  Validation of the reference tissue model for estimation of dopaminergic D2-like receptor binding with [18F](N-methyl)benperidol in humans.

Authors:  Jo Ann V Antenor-Dorsey; Joanne Markham; Stephen M Moerlein; Tom O Videen; Joel S Perlmutter
Journal:  Nucl Med Biol       Date:  2008-04       Impact factor: 2.408

Review 4.  Positron emission tomography applied in the study of pituitary adenomas.

Authors:  C Muhr; M Bergström
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

Review 5.  PET: a biological imaging technique.

Authors:  M E Phelps
Journal:  Neurochem Res       Date:  1991-09       Impact factor: 3.996

Review 6.  Structural and functional brain imaging in schizophrenia.

Authors:  J M Cleghorn; R B Zipursky; S J List
Journal:  J Psychiatry Neurosci       Date:  1991-07       Impact factor: 6.186

7.  Analysis of three- and four-compartment models for in vivo radioligand-neuroreceptor interaction.

Authors:  B R Zeeberg; H N Wagner
Journal:  Bull Math Biol       Date:  1987       Impact factor: 1.758

8.  Theoretical effects of radioligand diffusional gradients and microscopic neuroreceptor distribution in in vivo kinetic studies.

Authors:  B R Zeeberg; R C Reid; K A Murphy; R C Reba
Journal:  Bull Math Biol       Date:  1988       Impact factor: 1.758

9.  Quantification of baboon cortical S2 serotonin receptors in vivo with 3-N-(2'-F18)fluoroethylspiperone and positron emission tomography.

Authors:  S Jovkar; K Wienhard; H H Coenen; G Pawlik; W D Heiss
Journal:  Eur J Nucl Med       Date:  1991

10.  Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study.

Authors:  Aurelija Jucaite; Ikuo Odano; Hans Olsson; Stefan Pauli; Christer Halldin; Lars Farde
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-03       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.